First Horizon Corporation’s Health Catalyst HCAT Stock Holding History

First Horizon Corporation’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,500	Closed	-$1.91K	–	1558
2026 Q1	$1.91K	Hold	1,500	–	–	﹤0.01%	1280
2025 Q4	$3.58K	Hold	1,500	–	–	﹤0.01%	1259
2025 Q3	$4.28K	Buy	+1,500	New	+$5.13K	﹤0.01%	1209

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Horizon Corporation's HCAT Position: Q2 2026 in Review

First Horizon Corporation sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 1,500 shares — an estimated $1.91K sold.

First Horizon Corporation first reported a position in HCAT in Q3 2025 and held it in 3 quarters. The position peaked at $4.28K in Q3 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

First Horizon Corporation reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
First Horizon Corporation sold 1,500 Health Catalyst shares in Q2 2026, an estimated $1.91K.
First Horizon Corporation first reported a position in Health Catalyst in Q3 2025 and held it in 3 quarters.
First Horizon Corporation's Health Catalyst position peaked at $4.28K in Q3 2025.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.